Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,500
Closed -$172K 110
2025
Q2
$172K Sell
17,500
-7,500
-30% -$62.1K 0.44% 67
2025
Q1
$182K Buy
25,000
+13,714
+122% +$120K 0.53% 58
2024
Q4
$88.3K Buy
11,286
+2,500
+28% +$20.6K 0.17% 93
2024
Q3
$65K Hold
8,786
0.1% 83
2024
Q2
$70.4K Hold
8,786
0.09% 86
2024
Q1
$102K Sell
8,786
-200
-2% -$2.21K 0.1% 90
2023
Q4
$100K Sell
8,986
-6,014
-40% -$55.3K 0.07% 108
2023
Q3
$232K Hold
15,000
0.06% 110
2023
Q2
$284K Hold
15,000
0.06% 108
2023
Q1
$228K Buy
+15,000
New +$196K 0.04% 127

Other funds holding ETNB

Sandia Investment Management's ETNB Position: Q3 2025 in Review

Sandia Investment Management sold out of 89bio (ETNB) in Q3 2025, closing a stake of 17,500 shares — an estimated $172K sold.

Sandia Investment Management first reported a position in ETNB in Q1 2023 and held it in 10 quarters. The position peaked at $284K in Q2 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Sandia Investment Management reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Sandia Investment Management sold 17,500 89bio shares in Q3 2025, an estimated $172K.
  • Sandia Investment Management first reported a position in 89bio in Q1 2023 and held it in 10 quarters.
  • Sandia Investment Management's 89bio position peaked at $284K in Q2 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Sandia Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.